RNA product transfer questionnaire for sponsor and contract organization
Interest in RNA therapeutics is growing rapidly within the pharmaceutical industry, it has the potential to treat and prevent many human diseases while being relatively safe and cost effective. This promise has led sponsors to actively research RNA based drugs for a broad array of applications. Sponsors regularly use contract organisations for development and manufacture of RNA products, while interaction with contract organizations for regular biologics is widely established and has been routinely performed by Sponsors, it is still in infancy stage for RNA products. The unique aspects of RNA can result in unique challenges that may not be addressed if the same process of standard biologics transfer is followed, making the requirements for RNA products potentially less clear. Furthermore, some contract organizations are new to the RNA field and thus might overlook important RNA specific considerations.
Sponsors and contract organizations are in need of defining requirements early in the new product introduction (NPI) process to reduce the risk of unplanned disruptions and delays. This BioPhorum member only questionnaire presents a tool for sponsors to ascertain the suitability of the contract organization services and for the contract organizations to understand the scope, requirements, and timelines of the RNA transfer project.
I don't have access to this document
Make a selection below and submit your request. We will get back to you ASAP.
My company would like to become a member
If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.
